Regulatory

CIRS RD Briefing 97 – Access Consortium and Project Orbis Approvals Across Eight Regulators

This R&D Briefing builds upon the Centre for Innovation in Regulatory Science (CIRS)'s long-standing efforts to examine trends and practices in regulatory approvals. For over 20 years, CIRS has [...]

Frequency and Variation of Clock-Stop During EMA Assessment for Oncology Products – Implication on JCA Timelines

Objectives: The implementation act adopted for the HTA Regulation (HTAR) defined the timelines of scoping, submission and assessment and output of Joint Clinical Assessment (JCA), which will be in [...]

2024-11-28T14:31:01+00:00November 28th, 2024|Tags: , , , |
Go to Top